Most recently, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and will not activate a next messenge